Ipilimumab vs Trastuzumab Emtansine
Ipilimumab vs Trastuzumab Emtansine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Trastuzumab Emtansine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Trastuzumab Emtansine — Antibody drug conjugate.